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httpIntraoperative blood transfusion of one or two
units of packed red blood cells is associated with
a ﬁvefold risk of stroke in patients undergoing
elective carotid endarterectomy
Chen Rubinstein, MD,a Daniel L. Davenport, PhD,a Rebekah Dunnagan,c Sibu P. Saha, MD,b
Victor A. Ferraris, MD,b and Eleftherios S. Xenos, MD, PhD,a Lexington, Ky
Objective: Transfused blood can disrupt the coagulation cascade. We postulated that packed red blood cell (PRBC)
transfusion may be associated with thromboembolic phenomena. We used propensity matching to examine the
relationship between intraoperative PRBC transfusion and stroke during carotid endarterectomy (CEA).
Methods: We selected CEA procedures from the American College of Surgeons National Surgical Quality Improvement
Program database from 2005-2009. We excluded bilateral, redo, and emergent procedures. We used multivariate logistic
regression to identify independent risk factors for stroke. We then calculated a transfusion propensity score to match
patients who received one or two units of transfused PRBC intraoperatively with patients of similar risk proﬁles who had
not been transfused.
Results: Our criteria resulted in 12,786 elective CEA patients. Of these, 82 (0.6%) received a one- to two-unit intra-
operative transfusion. Thirty-day stroke rates were 1.4% (179/12,704) in the nontransfused group and 6.1% (5/82) in
the transfused group (Fisher exact test, P [ .007). In forward stepwise multivariable regression of risk factors, only
hemiplegia, stroke history, and transient ischemic attacks were predictive of 30-day stroke. We used these same variables
to calculate transfusion propensity. We matched 80 transfused patients with 160 controls, thus, creating two groups with
very similar risk proﬁles differing only by their transfusion status. In the matched groups, there was a ﬁvefold increase in
the risk of stroke in transfused patients (Fisher exact test, P [ .043)
Conclusions: Intraoperative transfusion of one to two units of PRBCs is associated with a ﬁvefold increase in stroke risk.
This holds true after consideration of stroke risk variables and operative duration as a surrogate for technical difﬁculty.
The increased risk may be related to several effects of transfused blood on the coagulation inﬂammation cascade. (J Vasc
Surg 2013;57:53S-7S.)Stroke, the fourth leading cause of death in the United
States behind coronary artery disease and cancer, accounts
for approximately one of every 18 deaths occurring annually
in the United States. Each year, roughly 795,000 people
experience a new or recurrent stroke; on average, 610,000
are shown to be ﬁrst attacks whereas 185,000 are recurrent.1
According to the National Institute of Neurological Disor-
ders and Stroke, 2 to 3 million Americans who have survived
a stroke are shown to have sustained some form of perma-
nent disability; furthermore, stroke is estimated to cost the
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://dx.doi.org/10.1016/j.jvs.2012.07.059atherosclerosis is a risk factor for embolic stroke. Carotid
endarterectomy (CEA), the “gold standard” in the treatment
of symptomatic and asymptomatic carotid artery stenosis,2
rarely requires perioperative transfusion. Perioperative blood
transfusionhasbeenpreviously linkedwithnumeroushazards
including increased infection rates,malignancies (non-Hodg-
kin’s lymphoma), transfusion-related acute lung injury, and
thrombotic events in various surgical settings,3 however, no
data currently exist linking packed red blood cell (PRBC)
transfusion topoorer neurologicoutcome inCEA.Tradition-
ally, previous patient transfusion experiences have governed
the amount of PRBC that is to be typed and cross-matched
for certain surgical procedures, with an average of about
two units forCEAs.4 Although studies of representative insti-
tutions indicate that PRBC is still being ordered excessively
nationwide, the amount of PRBC transfused in the perioper-
ative period has decreased signiﬁcantly because of increased
awareness of transfusion-associated risks and increasing
cost. In light of (1) stroke is a periprocedural risk following
CEAwith signiﬁcant social andﬁnancial burden and (2) intra-
operative PRBC transfusion, which has been previously
linked with hypercoagulable and embolic events, is still prac-
ticed within CEA, analysis is warranted looking at the direct
relationship between intraoperative PRBC transfusion and
perioperative stroke following CEA.53S
Table I. Multivariate ORs for 30-day stroke with deﬁcit after initial elective CEA (n ¼ 12,786)
Variable Incidence n or mean (%) 6 SD OR (95% CI) Signiﬁcance
Transfused 1-2 units vs none 82 (0.6) 4.75 (1.75-12.86) 0.002
Preop hemiplegia/hemiparesis 554 (4.3) 2.35 (1.37-4.04) 0.002
Hx transient ischemic attacks 3204 (25.1) 1.43 (1.05-1.95) 0.023
Hx CVA/stroke w/neurologic deﬁcit 1587 (12.4) 2.00 (1.30-3.08) 0.002
Hx CVA/stroke w/o neurologic deﬁcit 1028 (8.0) 2.22 (1.44-3.43) 0.000
Female sex 5317 (41.6) 1.13 (0.83-1.53) 0.436
Age, years 71.1 6 9.4 1.00 (0.99-1.02) 0.804
Operative duration vs #80 minutes 2674 (20.9) 0.969
81-99 minutes 2448 (19.1) 0.86 (0.54-1.38) 0.537
100-119 minutes 2598 (20.3) 0.90 (0.57-1.42) 0.661
120-147 minutes 2586 (20.2) 0.88 (0.56-1.40) 0.600
>147 minutes 2480 (19.4) 0.96 (0.61-1.51) 0.873
Preop HCT group vs >40% 6248 (48.9) 0.831
#25 41 (0.3) 1.21 (0.16-9.26) 0.852
26-30 306 (2.4) 0.73 (0.28-1.93) 0.525
31-35 1646 (12.9) 0.89 (0.56-1.41) 0.622
36-40 4545 (35.5) 0.83 (0.59-1.16) 0.283
CEA, Carotid endarterectomy; CI, conﬁdence interval; CVA, cerebrovascular accident; HCT, hematocrit; OR, odds ratio; SD, standard deviation.
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We selected CEA procedures from the American
College of Surgeons National Surgical Quality Improve-
ment Program (ACS NSQIP) dataset from the years
2005 to 2009 (primary procedure Current Procedural
Terminology code 35301 and operative diagnosis Interna-
tional Classiﬁcation of Diseases, 9th Revision code 43x.x or
44x.x). We excluded bilateral and reoperations, as well as
patients with any secondary procedures other than radio-
graphic or other tests (Doppler scan, etc). We also
excluded emergent cases, patients without ACS/NSQIP
documentation of timely discontinuance of blood thinners,
patients with known preoperative transfusion, intraopera-
tive transfusion of three or more units, or postoperative
transfusion. We also excluded patients with preoperative
impaired sensorium, coma, or totally dependent functional
status and/or a central nervous system tumor. We also
excluded patients without preoperative hematocrit values.
The ACS NSQIP dataset contains data from a prospec-
tive, systematic study of patients undergoing major surgical
procedures at over 200 hospitals. In participating hospitals,
a data coordinator collected over 50 preoperative patient
characteristics, intraoperative processes of care, and 22 uni-
formly deﬁned postoperative adverse occurrences (including
death and stroke with deﬁcit) up to 30 days after the opera-
tion. Risk and outcome variables were rigorously deﬁned,
and coordinators had previously completed in-depth training
on all study deﬁnitions. Thirty-day follow-up information
was obtained through phone calls, letters, and review of
clinic/hospitalmedical records. Additional operations within
30 days of an included case were excluded. Patients less than
18 years old and admissions for trauma were excluded.
Our primary outcome was stroke with neurologic deﬁcit
within 30 days of CEA. We compared stroke rates in the
transfused and nontransfused populations using Fisher exact
test.We performed forward stepwise logistic regression of allthe over 50 ACS NSQIP patient and perioperative risk
factors vs postoperative stroke with deﬁcit within 30 days
of operation. To these independent predictors, we added
sex, age, operative duration, and preoperative hematocrit
to the ﬁnal regression model. We used independent
risk factors identiﬁed for stroke in the ﬁrst regression in
a second logistic regression of whether the patient received
a transfusion or not. The resulting estimated probability
of transfusion was used as a transfusion propensity score.
We then used greedy, nearest neighbor matching (essen-
tially the closest match found) on the logit of the propensity
score (within a maximum range of 0.2 SDs) to match
transfused patients (one to two units only) with two
nontransfused controls (2:1 match) of similar stroke risk.
We measured the effectiveness of our propensity matching
by calculating the standardized difference between variables
in the two groups. We set the threshold for signiﬁcant
differences as greater than 0.1.
RESULTS
Our strict inclusion criteria resulted in 12,786 elective,
initial, isolated CEA procedures. Of these, only 82 (0.6%)
received a one- to two-unit intraoperative transfusion.
The transfusions were almost evenly split, 44 patients
received one unit (stroke 3/44, 6.8%, mortality 0/44)
and 38 patients received two units (stroke 2/38 5.3%,
mortality 2/38 5.3%). Looking at the two groups
combined (82 patients), 30-day stroke rates were 1.4%
(179/12,704) in the nontransfused group and 6.1% (5/
82) in the transfused group (Fisher exact test, P ¼ .007).
Thirty-day mortality was 0.6% (70/12,704) in the non-
transfused group and 2.4% (2/82) in the transfused group
(Fisher exact test, P ¼ .078).
In forward stepwise multivariable regression of the over
50 clinical patient risk factors, only hemiplegia, stroke
history (with and without deﬁcit), and transient ischemic
Table II. Balance of risk factors between propensity-matched cohorts of patients undergoing CEA; transfused one or two
units vs nontransfused controls (n ¼ 240)
Risk variable
Nontransfused, No. (%)
or mean 6 SD
Transfused (1-2 units), No. (%)
or mean 6 SD Standardized difference
No. of patients in cohort 160 80
Age, mean years 6 SD 75.1 6 8.1 74.3 6 8.7 0.01
Male 83 (51.9) 43 (53.8) 0.04
Hx hemiplegia, No. (%) 4 (2.5) 2 (2.5) 0
Hx TIA, No. (%) 49 (30.6) 25 (31.3) 0.01
Hx CVA w/neurologic deﬁcit, No. (%) 15 (9.4) 8 (10.0) 0.02
Hx CVA w/o neurologic deﬁcit, No. (%) 14 (8.8) 7 (8.8) 0
Preop hematocrit group
>40.0, No. (%) 18 (11.0) 9 (11.0) 0
35.1-40.0, No. (%) 34 (20.7) 17 (20.7) 0
30.1-35.0, No. (%) 44 (26.8) 22 (26.8) 0
25.1-30.0, No. (%) 56 (35.0) 28 (35.0) 0
#25, No. (%) 8 (4.9) 4 (4.9) 0
Operative duration quintile
#80 minutes, No. (%) 28 (17.5) 11 (13.8) 0.1
81-99 minutes, No. (%) 14 (8.8) 9 (11.3) 0.08
100-119 minutes, No. (%) 27 (16.9) 13 (16.3) 0.02
120-147 minutes, No. (%) 20 (12.5) 10 (12.5) 0
>147 minutes, No. (%) 71 (44.4) 37 (46.3) 0.04
CEA, Carotid endarterectomy; CVA, cerebrovascular accident; SD, standard deviation; TIA, transient ischemic attack.
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Society of Anesthesiology class, functional status, serum
albumin, and numerous others were not independent
predictors of stroke in this patient population. We added
transfusion status, sex, age, operative duration, and hemat-
ocrit into the regression model along with the stroke
history variables, and the results are shown in Table I.
With multivariable adjustment, the OR for postoperative
stroke was 4.75 (95% CI, 1.75-12.86; P ¼ .002) in trans-
fused vs nontransfused patients.
We used these same risk variables to calculate the
propensity score and were able to closely match 80 trans-
fused patients with 160 controls. The standardized differ-
ences between risk variables are less than 0.1 for all
variables indicating homogeneous matching on known
risk factors (Table II). The relative risk for stroke was 5.0
in the transfused group vs the matched controls (Fisher
exact test, P ¼ .043; Table III). This is similar to the
adjusted OR from the multivariate regression.
DISCUSSION
Blood transfusion is an uncommon event during carotid
endarterectomies. We found increased risk of postoperative
stroke in patients receiving one or two units of transfused
PRBC during initial, elective, and isolated carotid endarter-
ectomies. An almost ﬁvefold risk for stroke-related to one-
to two-unit transfusion was determined in both multivariate
logistic regression and propensity-matched analysis. We
chose our analysis in the one- to two-unit cohort because
these quantities are potentially unrelated to acute anemia
and may represent more discretionary transfusion after
adjusting for preoperative hematocrit.
Ischemic strokes can be associated with blood transfu-
sion in a variety of mechanisms. Not only viscosity changesthat result from the increased hematocrit, but multiple
biochemical and molecular mechanisms may contribute
to this phenomenon. The main objective of PRBC transfu-
sion is to increase tissue oxygenation, thereby reducing
tissue oxygen debt. However, most transfusions given to
critical patients consist of PRBCs stored >20 days, and
the efﬁcacy of the stored blood for increasing oxygenation
has been questioned, as stored PRBCs have low levels of
2,3-diphosphoglycerate and adenosine triphosphate and
low deformability.5 Storage of RBCs results in a series
of morphologic and biochemical changes, collectively
referred to as RBC storage lesion6 that hinder their func-
tion after transfusion. During the ﬁrst 2 weeks of storage,
most 2,3-diphosphoglycerate is lost from the RBC. This
causes an increase in the oxygen afﬁnity of hemoglobin
leading to a diminished capacity of transfused erythrocytes
to release oxygen into the tissues. Another characteristic
alteration in stored RBCs is a change from their normal
biconcave shape to an echinocyte. This results in lower
surface-to-volume ratio, spherocytosis, increased cell he-
moglobin concentration and viscosity, increased osmotic
fragility, and loss of deformability. Red cells clump together
in storage.7 The longer the blood bags are stored, the
higher number of red cell clumps are present and the larger
the numbers of red cells in each of these clumps. From
some of the newest microcirculatory work in transfusion,
it has been shown that banked blood does not increase
oxygen delivery to tissues. Indeed, it may be responsible
for up to a 400% decrease in tissue oxygen delivery.8
Work in patients after coronary artery bypass surgery graft-
ing (CABG) surgery showed that there was no increase in
oxygen delivery to the microcirculation with one or two
units of blood.9 In some critically ill patients, it has been
shown that transfusing banked blood actually decreases
Table III. Relative risk for 30-day mortality and stroke in propensity-matched cohorts of patients undergoing CEA;
transfused one or two units vs nontransfused controls (n ¼ 240)
Outcome
Nontransfused
Transfused 1-2
units
Relative risk (95% CI) Exact P valueNo. % No. %
Cohort size 160 80
Mortality 2 1.3% 2 2.5% 2.0 (0.3-13.9) .602
Stroke 2 1.3% 5 6.3% 5.0 (1.0-25.2) .043
Stroke or mortalitya 4 2.5% 7 8.8% 3.5 (1.1-11.6) .045
CEA, Carotid endarterectomy; CI, conﬁdence interval.
aNo patient was recorded with both 30-day stroke and death, although this is possible in the National Surgical Quality Improvement Program protocol.
JOURNAL OF VASCULAR SURGERY
56S Rubinstein et al February Supplement 2013gut oxygen delivery making the tissues more acidotic.10
Therefore, the notion that one will increase oxygen
delivery to tissues with transfusion has been shown to be
not true in randomized trials.11
In a large (n ¼ 16,000), recently published analysis on
coronary bypass surgery,12 transfusion of more than four
units of PRBC was the strongest (OR ¼ 5) independent
predictor with respect to perioperative stroke; it is not clear
from this analysis whether transfusion support was a causa-
tive factor vs a predictor. Another recent publication
demonstrated a strong relationship between perioperative
platelet transfusion and both stroke and death after coro-
nary artery bypass surgery grafting.13
This literature as well as our ﬁndings supports an asso-
ciation between ischemic events and PRBC transfusion.
Blood transfusion is associated with a greater number of
ischemic events in patients undergoing percutaneous coro-
nary interventions for acute coronary syndromes (ACS).
Rao and colleagues assessed 24,111 patients with ACS in
a meta-analysis of three large trials investigating the relation
between transfusion and outcomes. The rates of 30-day
rates of death (8% vs 3.08%; P < .001), myocardial infarc-
tion (MI) (25.16% vs 8.16%; P < .001), and composite
death/MI (29.24% vs 10.02%; P < .001) were all signiﬁ-
cantly higher for patients receiving transfusions, with
a signiﬁcant interaction occurring at transfusion for a nadir
hematocrit value >25%.11 In non-ST elevation ACS,
regardless of the hemoglobin concentration, transfusion
was associated with an increased risk of the composite
end point (adjusted OR, 1.54; 95% CI, 1.14-2.09). The
reason for the differential effect of transfusion on patients
with ST-elevation MI and non-ST elevation ACS may be
related to a variety of factors, including local and systemic
hemodynamics, and further study will be required to deﬁn-
itively elucidate the appropriate use of blood product trans-
fusion in those with anemia and acute hemorrhage. Finally,
resting myocardial oxygen extraction is high (75%) and can
be augmented only via increased coronary blood ﬂow. A
major contributor to increasing coronary blood ﬂow is
nitric oxide–mediated vasodilatation, which has been
proven to increase oxygen delivery to the myocardium via
the large coronary arteries. Nitric oxide serves a role in
oxygen exchange, has a short half-life, and has been shownto be decreased in stored blood.14 Therefore, stored red
blood cells devoid of nitric oxide may act as a vacuum,
depleting local levels of nitric oxide within coronary arteries
and causing localized vasoconstriction and tissue hypoxia.
Retrospective analysis provided by the Mayo Clinic
(Rochester, Minn), involving the evaluation of red blood
cell (RBC) transfusion practices over the past 15 years and
the inﬂuence of changes on neurologic or cardiac morbidity
after CEA, indicated that, in general, a lower transfusion
trigger was developed within older patients showing
increased comorbidity.15 The frequency of perioperative
stroke and MI between two stratiﬁed groups of patients
(an early-practice group of patients admitted from 1980 to
1985 and a recent-practice group admitted from 1990 to
1995) was not observed to have been signiﬁcantly different.
Moreover, along with a decrease in RBCs during all phases
of the perioperative period, timing as to administration of
transfusion shifted from intraoperative to postoperative in
later years. Modest perioperative anemia was not found to
increase the risk of perioperative cerebral and cardiac
ischemia in patients during CEA.
Our analysis was limited by the low incidence of trans-
fusion (0.6%) and stroke (1.4%) with CEA. Any analysis of
stroke and transfusion will necessarily suffer from these
limitations. Our systematically obtained sample of over
12,000 initial, isolated, carotid endarterectomies in the
ACS NSQIP certainly is close to the largest study of its
kind. It has many more patients than conceivable in any
randomized clinical trial of transfusion, which is unlikely
to be performed. We do not have information regarding
the use of statins and antiplatelet agents, as the ACS
NSQIP does not capture them. We do not have data
regarding the postoperative hematocrit or hemoglobin
and therefore cannot exclude over transfusion in some of
these cases. For statistical reasons, we were unable to sepa-
rate the patients who received one unit from those who
received two units of PRBC. The dataset does not have
intraoperative blood pressures or hypotensive events.
We do not have information about the use of shunt or
patch during the procedure. We adjusted for operative
duration as a placeholder for technical complexity as well
as past stroke history and preoperative hematocrit. It is
conceivable that technical difﬁculty may be related to
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 2S Rubinstein et al 57Sintraoperative blood transfusion. The dataset lacks infor-
mation regarding the reason for the transfusion; however,
our ﬁndings as well as the association between hypotension
and stroke, may suggest that these patients be better served
by maintaining normotension rather than blood transfu-
sion. We also do not have information regarding the age
of the PRBCs and whether or not leukoreduction was
performed.
CONCLUSIONS
In summary, we used CEA as a model to examine the
effect of PRBC transfusion on neurologic outcome. Our
ﬁndings indicate that erythrocyte transfusion is associated
with an increased risk for stroke, possibly because of the
hypercoagulable and inﬂammatory reactions that they
provoke.
The American College of Surgeons National Surgical
Quality Improvement Program and the hospitals partici-
pating in the ACS NSQIP are the source of the data
used herein; they have not been veriﬁed and are not
responsible for the statistical validity of the data analysis
or the conclusions derived by the authors.
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